Center for Drug Evaluation and Research growing crisis around HIV testing and treatment and an inter-agency dispute between officials from the former Bureau of Drugs and officials from the former Bureau of Biologics over whether to approve Genentech's Activase (tissue plasminogen activator) led to the split. In its original form, CDER was composed of six offices: Management, Compliance, Drug Standards, Drug Evaluation I, Drug Evaluation II, Epidemiology and Biostatistics, and Research Resources. The Division of Antiviral Products was added in 1989 under Drug Evaluation II due to the large amount of drugs proposed for treating AIDS. The Office of Generic Drugs was also formed. In 2002,
Arguments for and against drug prohibition succession of committees and reports including, in the United Kingdom alone, the Police Foundation, the Home Affairs Select Committee, the Prime Minister's Strategy Unit, the Royal Society of Arts, and the UK Drug Policy Consortium. The United Nations Office of Drugs and Crime has also acknowledged the many "unintended negative consequences" of drug enforcement. The editor of the "British Medical Journal", Dr. Fiona Godlee, gave her personal support to Rolles' call for decriminalisation, and the arguments drew particular support from Sir Ian Gilmore, former president of the Royal College of Physicians, who said we should be treating drugs "as a